相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Usmarapride (SUVN-D4010), a 5-HT4 receptor partial agonist for the potential treatment of Alzheimer?s disease: Behavioural, neurochemical and pharmacological profiling
Ramakrishna Nirogi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2023)
Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions
Dong-Chen Xu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)
Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease
Martina Mazzocchi et al.
BRAIN BEHAVIOR AND IMMUNITY (2022)
Pharmacological Modulation of TRPM2 Channels via PARP Pathway Leads to Neuroprotection in MPTP-induced Parkinson's Disease in Sprague Dawley Rats
Bhupesh Vaidya et al.
MOLECULAR NEUROBIOLOGY (2022)
Inflammation and immune dysfunction in Parkinson disease
Malu Gamez Tansey et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Metformin ameliorates the status epilepticus- induced hippocampal pathology through possible mTOR modulation
Sree Lalitha Bojja et al.
INFLAMMOPHARMACOLOGY (2021)
Parkinson's disease
Bastiaan R. Bloem et al.
LANCET (2021)
Epigenetic Modulation in Parkinson's Disease and Potential Treatment Therapies
Aaina Singh Rathore et al.
NEUROCHEMICAL RESEARCH (2021)
Histone Deacetylase Inhibitors Prevented the Development of Morphine Tolerance by Decreasing IL6 Production and Upregulating μ-Opioid Receptors
Sahil Jindal et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2021)
Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer's disease
Sampath Kumar L. Rompicherla et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2021)
Antidepressant-like effect of dehydrozingerone from Zingiber officinale by elevating monoamines in brain: in silico and in vivo studies
Sudheer Moorkoth et al.
PHARMACOLOGICAL REPORTS (2021)
Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis
Simona-Adriana Manea et al.
REDOX BIOLOGY (2020)
Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation
Surabhi Shukla et al.
FRONTIERS IN PHARMACOLOGY (2020)
Cinnamyl Sulfonamide Hydroxamate Derivatives Inhibited LPS-Stimulated NF-κB Expression in RAW 264.7 Cells In Vitro and Mitigated Experimental Colitis in Wistar Rats In Vivo
Mit Joshi et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications
Marta Pajares et al.
CELLS (2020)
Entanglement of Genetics and Epigenetics in Parkinson's Disease
H. J. van Heesbeen et al.
FRONTIERS IN NEUROSCIENCE (2019)
The current status of pharmacotherapy for the treatment of Parkinson's disease: transition from single-target to multitarget therapy
Siew L. Cheong et al.
DRUG DISCOVERY TODAY (2019)
HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic Mice
Taewoo Kim et al.
EXPERIMENTAL NEUROBIOLOGY (2019)
Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice
Devinder Arora et al.
METABOLIC BRAIN DISEASE (2018)
Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson's disease
Gourav R. Choudhury et al.
PLOS ONE (2018)
The Emerging Evidence of the Parkinson Pandemic
E. Ray Dorsey et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Non-motor features of Parkinson disease
Anthony H. V. Schapira et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Oxidative stress and cellular pathologies in Parkinson's disease
Lesly Puspita et al.
MOLECULAR BRAIN (2017)
The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: Possible relevance for treatment-resistant depression
Elsa M. Meylan et al.
NEUROPHARMACOLOGY (2016)
The potential use of histone deacetylase inhibitors in the treatment of depression
Manabu Fuchikami et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
Elizabeth E. Hull et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity
Sorabh Sharma et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors
Ian F. Harrison et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
In vitro and in vivo evaluation of novel cinnamyl sulfonamide hydroxamate derivative against colon adenocarcinoma
Neetinkumar D. Reddy et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
PINK1 positively regulates HDAC3 to suppress dopaminergic neuronal cell death
Hyo-Kyoung Choi et al.
HUMAN MOLECULAR GENETICS (2015)
Hesperidin potentiates the neuroprotective effects of diazepam and gabapentin against pentylenetetrazole-induced convulsions in mice: Possible behavioral, biochemical and mitochondrial alterations
Anil Kumar et al.
INDIAN JOURNAL OF PHARMACOLOGY (2014)
α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
Eirene Kontopoulos et al.
HUMAN MOLECULAR GENETICS (2006)
分享论文
